Physician

Julie Christine Plante, MD

According to 2025 Medicare claims, Julie Plante, MD (NPI: 1346426848) practices dermatology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is INTEGRATED DERMATOLOGY OF SANTA ROSA, PC (NPI: 1508441247; TIN: 86-1622079) and primary practice location at 95448-9998.

Plante's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,163 traditional Medicare patients, billed 7,766 HCPCS/CPT codes, and received $394,089 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,225 prescription claims across 482 beneficiaries totaling $664,294 in drug costs, led by Odomzo (Sonidegib Phosphate). Open Payments data shows 16 records totaling $450. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $110,964 to $664,294. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$197K$394K2015 Medicare payment: $364,434 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $325,912 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $159,064 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $156,679 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $188,252 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $239,153 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $251,861 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $339,466 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $356,649 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $394,089 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,4988,835$364,434
20161,5619,183$325,912
20178504,588$159,064
20187774,179$156,679
20198674,283$188,252
20201,0265,484$239,153
20219315,381$251,861
20221,0226,995$339,466
20231,0816,946$356,649
20241,1637,766$394,089

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$377K$755K2015 Drug cost: $110,964 (USD; Tot_Drug_Cst)2016 Drug cost: $195,007 (USD; Tot_Drug_Cst)2017 Drug cost: $103,608 (USD; Tot_Drug_Cst)2018 Drug cost: $241,046 (USD; Tot_Drug_Cst)2019 Drug cost: $264,503 (USD; Tot_Drug_Cst)2020 Drug cost: $446,306 (USD; Tot_Drug_Cst)2021 Drug cost: $382,314 (USD; Tot_Drug_Cst)2022 Drug cost: $754,779 (USD; Tot_Drug_Cst)2023 Drug cost: $594,143 (USD; Tot_Drug_Cst)2024 Drug cost: $664,294 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015428840$110,964
20164841,025$195,007
2017280508$103,608
2018294597$241,046
2019260517$264,503
20204491,045$446,306
2021396926$382,314
20224381,178$754,779
20235031,114$594,143
20244821,225$664,294

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7291,067$73
11102Biopsy of related skin growth, first growth422534$70
17000Destruction of precancer skin growth, 1 growth627868$40
88305Pathology examination of tissue using a microscope, intermediate complexity374655$30
17003Destruction of precancer skin growth, 2-14 growths4522,462$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OdomzoSonidegib Phosphate19570$285,540
Humira(Cf) PenAdalimumab14392$94,231
OtezlaApremilast19570$87,768
Dupixent PenDupilumab12322$44,503
MetronidazoleMetronidazole511,775$3,144

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$450ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Julie Christine Plante, MD?

Tedicare shows public-source Medicare data for Julie Christine Plante, MD (NPI 1346426848), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julie Christine Plante, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Julie Christine Plante, MD?

Julie Christine Plante, MD is linked to INTEGRATED DERMATOLOGY OF SANTA ROSA, PC (billing NPI 1508441247) in the available physician profile data.

Does Julie Christine Plante, MD have Open Payments data?

Julie Christine Plante, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.